John R. Thomas (professor)

Last updated March 27, 2023

John R. "Jay" Thomas (born 1967)^[1] is a professor of law at Georgetown University Law Center.

Early life and education

Thomas received a B.S. in Computer Engineering from Carnegie Mellon University. He earned a J.D. from the University of Michigan and an LL.M. from the George Washington University Law School.^[2]

Career

After law school, he was a law clerk to Helen W. Nies, then Chief Judge of the United States Court of Appeals for the Federal Circuit.^[2]

Since 1999, Thomas has served as a visiting scholar at the Congressional Research Service. In that capacity he assisted members of Congress and their staff during the enactment of such legislation as the American Inventors Protection Act and the America Invents Act. Thomas served as the Thomas Alva Edition Fellow at the United States Patent and Trademark Office.^[2] He has been a member of the faculties of Cornell University, George Washington University (and an assistant professor at the its law school) and the University of Tokyo. He has served as a visiting scholar at the Max Planck Institute for Intellectual Property and Competition Law in Munich, Germany, and the Institute of Intellectual Property in Tokyo, Japan.^[2]

The 2005 first edition of his Pharmaceutical Patent Law was well-reviewed by Dennis Crouch of Patently-O, who described it as "an excellent treatise that will be very well regarded for years to come" and "surprisingly readable".^[3] In 2019, Thomas suggested that patent "march-in rights", which permit the U.S. government to force licensure of certain patents, "might make drugmakers pause" before exacting excessive prices for their products,^[4] a view for which Thomas was criticized by Joseph Allen of IPWatchdog, who asserted that in a previous Congressional Research Service report, Thomas appeared to assert that such use of march-in rights would require further Congressional action.^[5]

Works

Thomas has authored and co-authored many books, primarily in the field of intellectual property.

Thomas, John R. (2019). Pharmaceutical Patent Law. Washington, D.C.: Bureau of National Affairs 3d ed. 2015 & Supp.^[3]
Thomas, John R.; Schechter, Roger E. (2019). Principles of Patent Law. St. Paul, Minnesota: Thomson/West.
Thomas, John R.; Abramson, Brian Dean; Safir, Peter O. (2018). Vaccine, Vaccination, and Immunization Law. Washington, D.C.: Bloomberg Law.^[1]
Thomas, John R.; Adelman, Martin J.; Rader, Randall R. (2018). Cases and Materials on Patent Law (5th ed.). St. Paul, Minnesota: West.
Thomas, John R. (2015). Pharmaceutical Patent Law (3rd ed.). Arlington, Virginia: Bureau of National Affairs.
Thomas, John R.; Schechter, Roger E. (2010). Principles of Copyright Law. St. Paul, Minnesota: West.
Thomas, John R. (2005). Intellectual Property and the Free Trade Agreements (PDF). Washington, D.C.: Congressional Research Service.
Thomas, John R.; Adelman, Martin J.; Rader, Randall R.; Wegner, Harold C. (2003). Cases and Materials on Patent Law (2nd ed.). St. Paul, Minnesota: Thomson/West. ISBN 9780314246370.
Thomas, John R.; Schechter, Roger E. (2003). Intellectual Property: The Law of Copyrights, Patents, and Trademarks. St. Paul, Minnesota: Thomson/West.

Related Research Articles

The United States Patent and Trademark Office (USPTO) is an agency in the U.S. Department of Commerce that serves as the national patent office and trademark registration authority for the United States. The USPTO's headquarters are in Alexandria, Virginia, after a 2005 move from the Crystal City area of neighboring Arlington, Virginia.

Diamond v. Chakrabarty, 447 U.S. 303 (1980), was a United States Supreme Court case dealing with whether living organisms can be patented. Writing for a five-justice majority, Chief Justice Warren E. Burger held that human-made bacteria could be patented under the patent laws of the United States because such an invention constituted a "manufacture" or "composition of matter". Justice William J. Brennan Jr., along with Justices Byron White, Thurgood Marshall, and Lewis F. Powell Jr., dissented from the Court's ruling, arguing that because Congress had not expressly authorized the patenting of biological organisms, the Court should not extend patent law to cover them.

Kenneth Lee Adelman is an American diplomat, political writer, policy analyst and William Shakespeare scholar. Adelman has been a member of the board of directors of the global data collection company RIWI Corp. since June 2016.

<span class="mw-page-title-main">Jon Dudas</span> American lawyer

Jonathan Ward "Jon" Dudas, born July 5, 1968, is the senior vice president, senior associate to the president and secretary of the University of Arizona. He previously served as Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO) until January 18, 2009. He was nominated to the position by former President George W. Bush in March 2004 and appointed in July 2004. Dudas previously served as acting Under Secretary and Director, and Deputy Under Secretary and Deputy Director from 2002 to 2004. He is also a member of the board of directors of Conversant Intellectual Property Management.

Paul Redmond Michel is a retired United States circuit judge of the United States Court of Appeals for the Federal Circuit and a former Chief Judge of that court.

<span class="mw-page-title-main">Richard Linn</span> American judge

Richard Linn is a Senior United States circuit judge of the United States Court of Appeals for the Federal Circuit.

J. Thomas McCarthy is a Professor Emeritus at the University of San Francisco School of Law. He is the founding director of the McCarthy Institute for Intellectual Property and Technology Law. He has practiced, written, and taught in the field of trademarks and unfair competition and was a frequent speaker on the subject. McCarthy is a member of the California and U.S. Supreme Court bars and is admitted to practice before the United States Patent and Trademark Office.

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations. TRIPS was negotiated at the end of the Uruguay Round of the General Agreement on Tariffs and Trade (GATT) between 1989 and 1990 and is administered by the WTO.

Q. Todd Dickinson was an Under Secretary of Commerce for Intellectual Property and director of the United States Patent and Trademark Office (USPTO). He was an executive director of the American Intellectual Property Law Association (AIPLA), and had been mentioned by some sources for possible reappointment to his former post as director of the USPTO by the Barack Obama administration prior to the appointment of David Kappos to that post.

Licensee estoppel is a doctrine under which a licensee of an intellectual property right, generally a patent or a trademark, is estopped from challenging the validity of the licensed property. The basis for the doctrine is the premise that a licensee should not be able to enjoy the benefit of an agreement and at the same time attack the validity of the intellectual property that forms the basis of the agreement.

A transitional phrase, in United States patent law, is a phrase that links the preamble of a patent claim to the specific elements set forth in the claim which define what the invention itself actually is. The transitional phrase acts as a limitation on the claim, indicating whether a similar device, method, or composition infringes the patent if it contains more or fewer elements than the claim in the patent.

Haldane Robert Mayer is a Senior United States circuit judge of the United States Court of Appeals for the Federal Circuit.

Randall Ray Rader is a former United States Circuit Judge and former Chief Judge of the United States Court of Appeals for the Federal Circuit.

<span class="mw-page-title-main">David Kappos</span>

David "Dave" J. Kappos is an attorney and former government official who served as Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO) from 2009 to 2013. Kappos is currently a partner at New York law firm Cravath, Swaine & Moore.

<i>Northwestern Journal of Technology and Intellectual Property</i> Academic journal

The Northwestern Journal of Technology and Intellectual Property is a law review published by an independent student organization at Northwestern University School of Law.

Reverse payment patent settlements, also known as "pay-for-delay" agreements, are a type of agreement that has been used to settle pharmaceutical patent infringement litigation, in which the company that has brought the suit agrees to pay the company it sued. That is, the patent holder pays the alleged infringer to stop its alleged infringing activity for some period of time and to stop disputing the validity of the patent. These agreements are distinct from most patent settlements, which usually involve the alleged infringer paying the patent holder.

Kara Farnandez Stoll is a United States circuit judge of the United States Court of Appeals for the Federal Circuit.

The Arco lamp is a modern overhead lamp designed by brothers Pier Giacomo and Achille Castiglioni for Flos in 1962. The lamp is characterized by a suspended spun aluminum pendant attached to an upright slab of Carrara marble via a large, arching arm made of stainless steel.

References

1 2 "Vaccine, Vaccination, and Immunization Law". Georgetown University Law Library. Retrieved February 6, 2021.
1 2 3 4 "John R. Thomas faculty page". Georgetown University Law Center . Retrieved February 5, 2021.
1 2 Crouch, Dennis (May 9, 2006). "Book Review: Pharmaceutical Patent Law". Patently-O.
↑ Bauman, Valerie (December 16, 2019). "Democrats Tout Federal Patent Take-Backs for Lowering Drug Costs". Bloomberg, L.P.
↑ Allen, Joseph (April 22, 2019). "The Washington Post Misses the Mark on March-In Rights". IPWatchdog.

External links

Kappos, David J.; Thomas, John R.; Bluestone, Randall J. (2008). "A Technological Contribution Requirement for Patentable Subject Matter: Supreme Court Precedent and Policy". Northwestern Journal of Technology and Intellectual Property. 6 (2): 152–170. Archived from the original on 2009-02-16. Retrieved 2010-10-07.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[VVI-1] 1 2 "Vaccine, Vaccination, and Immunization Law". Georgetown University Law Library. Retrieved February 6, 2021.

[Georgetown-2] 1 2 3 4 "John R. Thomas faculty page". Georgetown University Law Center . Retrieved February 5, 2021.

[Crouch-3] 1 2 Crouch, Dennis (May 9, 2006). "Book Review: Pharmaceutical Patent Law". Patently-O.

[4] Bauman, Valerie (December 16, 2019). "Democrats Tout Federal Patent Take-Backs for Lowering Drug Costs". Bloomberg, L.P.

[5] Allen, Joseph (April 22, 2019). "The Washington Post Misses the Mark on March-In Rights". IPWatchdog.

[1]

[2]

[3]

[4]

[5]